Filana Therapeutics, Inc. (FLNA): Shareholders' Equity
$74.40M
As of 2025-12-31
$68.14M
As of 2026-03-31
-31.1%
3-year compound annual growth
-4.2%
5-year compound annual growth
+9.7%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $74.40M | -48.9% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $145.70M | +6.0% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $137.47M | -39.6% | 2026-03-12, Balance as of period end |
| 2022-12-31 | $227.54M | -10.4% | 2025-03-03, Balance as of period end |
| 2021-12-31 | $253.91M | +175.4% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $92.20M | +317.2% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $22.10M | +12.6% | 2021-03-23, Balance as of period end |
| 2018-12-31 | $19.63M | +102.4% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $9.70M | -48.0% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $18.64M | -36.5% | 2018-02-06, Balance as of period end |
| 2015-12-31 | $29.37M | -26.7% | 2017-03-07, Balance as of period end |
| 2014-12-31 | $40.06M | -17.1% | 2017-03-07, Balance as of period end |
| 2013-12-31 | $48.30M | +267.7% | 2016-03-03, Balance as of period end |
| 2012-12-31 | $13.14M | -70.4% | 2015-02-18, Balance as of period end |
| 2011-12-31 | $44.39M | +34.8% | 2014-02-05, Balance as of period end |
| 2010-12-31 | $32.93M | -69.6% | 2013-02-08, Balance as of period end |
| 2009-12-31 | $108.25M | n/a | 2012-02-09, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $74.40M | -48.9% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $47.70M | -24.5% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $106.63M | n/m |
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | -$17.00M | n/m |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $104.71M | -40.5% |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | $111.38M | -28.5% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $83.05M | -37.6% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $98.37M | +14.0% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $41.77M | +217.7% |
Compare FLNA, CAMP, AARD, KYNB side by side · Screen every company in Pharmaceutical Preparations ↗